Bleakley Financial Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-20,619
Closed -$4.36M 950
2026
Q1
$4.36M Buy
+20,619
New +$4.44M 0.07% 239
2025
Q2
Sell
-18,994
Closed -$2.62M 574
2025
Q1
$2.62M Buy
18,994
+7,996
+73% +$1.02M 0.08% 205
2024
Q4
$1.3M Buy
10,998
+6,501
+145% +$759K 0.04% 351
2024
Q3
$497K Buy
4,497
+272
+6% +$28.4K 0.02% 603
2024
Q2
$415K Buy
4,225
+44
+1% +$4.48K 0.01% 664
2024
Q1
$468K Sell
4,181
-95
-2% -$10.3K 0.01% 630
2023
Q4
$431K Buy
4,276
+395
+10% +$39.2K 0.01% 632
2023
Q3
$337K Sell
3,881
-560
-13% -$50.6K 0.01% 651
2023
Q2
$420K Buy
4,441
+269
+6% +$22.7K 0.01% 631
2023
Q1
$315K Buy
4,172
+159
+4% +$12K 0.01% 696
2022
Q4
$309K Buy
+4,013
New +$305K 0.01% 687

Other funds holding CAH

Bleakley Financial Group's CAH Position: Q2 2026 in Review

Bleakley Financial Group sold out of Cardinal Health (CAH) in Q2 2026, closing a stake of 20,619 shares — an estimated $4.36M sold.

Bleakley Financial Group first reported a position in CAH in Q4 2022 and held it in 11 quarters. The position peaked at $4.36M in Q1 2026. 1,497 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Bleakley Financial Group reported no remaining Cardinal Health position as of Q2 2026 after selling out during the quarter.
  • Bleakley Financial Group sold 20,619 Cardinal Health shares in Q2 2026, an estimated $4.36M.
  • Bleakley Financial Group first reported a position in Cardinal Health in Q4 2022 and held it in 11 quarters.
  • Bleakley Financial Group's Cardinal Health position peaked at $4.36M in Q1 2026.
  • 1,497 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.